SPP1 and breast carcinoma: Since osteopontin, a metastasis promoter protein [46] and a marker of human breast cancer progression [14], [47], [48], is over-expressed in 468LN cells, this ligand may present an additional autocrine pathway for metastasis, at least in part by interaction with α9β1 via the RGD domain [14].